Attached files

file filename
EX-10.1 - NANO LABS 8K, CONFIDENTIAL DISCLOSURE AGREEMENT - Nano Labs Corp.nanolabsexh10_1.htm


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 8-K


CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


May 6, 2013
Date of Report (Date of earliest event reported)


NANO LABS CORP.
(Exact name of registrant as specified in its charter)

Colorado
333-171658
84-1307164
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

The Ford Building
615 Griswold Street, 17th Floor
Suite 1715
Detroit, Michigan
 
48226
(Address of principal executive offices)
 
(Zip Code)

(888) 806-2315
Registrant’s telephone number, including area code

N/A
 (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
__________
 
 
 
 
 

 
 
 
SECTION 1 – REGISTRANT’S BUSINESS AND OPERATIONS

Item 1.01   ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT

Confidential Disclosure Agreement

Effective on May 6, 2013, Nano Labs Corp., a Colorado corporation (the “Company”), entered into a confidential disclosure agreement (the “Disclosure Agreement”) with Dentsply International Inc., a Delaware corporation ("Dentsply"). Both the Company and Dentsply independently possess and will continue to acquire certain confidential and proprietary information concerning nano-materials for dental composites (the "Confidential Information"). In accordance with the terms and provisions of the Disclosure Agreement, both the Company and Dentsply desire to disclose certain of its respective Confidential Information to the other party Both parties agree to hold in confidence and not to use such Confidential Information except for evaluation, recommendations to and/or discussion with the other party and other purposes specifically requested by the owner of the Confidential Information. Lastly, both parties agree to take every reasonable precaution to safeguard the confidentiality of the other party's Confidential Information, including restriction of access to such Confidential Information to only essential employees, agents, and/or associates, and maintaining all documents, memoranda, correspondence, data, notebooks, reports, drawings, samples or records contianing such Confidential Information in a secure location.
 
SECTION 9 – FINANCIAL STATEMENTS AND EXHIBITS
 
Item 9.01   Financial Statements and Exhibits
 
(a) Financial Statements of Business Acquired.
 
Not applicable.
 
(b) Pro forma Financial Information.
 
Not applicable.
 
(c) Shell Company Transaction.
 
Not applicable.
 
(d) Exhibits.
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
NANO LABS CORP.
 
     
     
DATE:  May 24, 2013 /s/ Bernardo Camacho Chararria  
 
Name:  Bernardo Camacho Chararria
 
  Title:    President/Chief Executive Officer  
 
__________